nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—H1F0—hematologic cancer	0.319	0.906	CbGaD
Quetiapine—ABCB1—hematologic cancer	0.0329	0.0936	CbGaD
Quetiapine—ABCB1—Lenalidomide—hematologic cancer	0.00946	0.0283	CbGbCtD
Quetiapine—CYP3A7—Ifosfamide—hematologic cancer	0.00911	0.0273	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00911	0.0273	CbGbCtD
Quetiapine—CYP3A7—Imatinib—hematologic cancer	0.0087	0.026	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0087	0.026	CbGbCtD
Quetiapine—CYP3A5—Daunorubicin—hematologic cancer	0.00852	0.0255	CbGbCtD
Quetiapine—CYP2D6—Lomustine—hematologic cancer	0.00829	0.0248	CbGbCtD
Quetiapine—CYP3A5—Thalidomide—hematologic cancer	0.00776	0.0232	CbGbCtD
Quetiapine—CYP3A5—Teniposide—hematologic cancer	0.0074	0.0222	CbGbCtD
Quetiapine—CYP2D6—Idarubicin—hematologic cancer	0.00739	0.0221	CbGbCtD
Quetiapine—CYP2C19—Bortezomib—hematologic cancer	0.00719	0.0215	CbGbCtD
Quetiapine—CYP3A5—Ifosfamide—hematologic cancer	0.00683	0.0204	CbGbCtD
Quetiapine—CYP3A5—Imatinib—hematologic cancer	0.00653	0.0195	CbGbCtD
Quetiapine—CYP2D6—Hydroxyurea—hematologic cancer	0.00628	0.0188	CbGbCtD
Quetiapine—CYP2C19—Thalidomide—hematologic cancer	0.00626	0.0187	CbGbCtD
Quetiapine—CYP2C19—Teniposide—hematologic cancer	0.00597	0.0179	CbGbCtD
Quetiapine—CYP3A4—Bexarotene—hematologic cancer	0.00567	0.017	CbGbCtD
Quetiapine—ABCB1—Daunorubicin—hematologic cancer	0.00555	0.0166	CbGbCtD
Quetiapine—CYP2C19—Ifosfamide—hematologic cancer	0.00551	0.0165	CbGbCtD
Quetiapine—CYP2D6—Bortezomib—hematologic cancer	0.00546	0.0163	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00543	0.0163	CbGbCtD
Quetiapine—CYP3A7—Irinotecan—hematologic cancer	0.00543	0.0163	CbGbCtD
Quetiapine—ABCB1—Alitretinoin—hematologic cancer	0.00543	0.0163	CbGbCtD
Quetiapine—CYP3A4—Lomustine—hematologic cancer	0.00527	0.0158	CbGbCtD
Quetiapine—CYP3A4—Busulfan—hematologic cancer	0.00527	0.0158	CbGbCtD
Quetiapine—CYP2C19—Imatinib—hematologic cancer	0.00526	0.0158	CbGbCtD
Quetiapine—CYP3A5—Dasatinib—hematologic cancer	0.00524	0.0157	CbGbCtD
Quetiapine—CYP3A7—Vincristine—hematologic cancer	0.00475	0.0142	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00475	0.0142	CbGbCtD
Quetiapine—CYP3A4—Thiotepa—hematologic cancer	0.0047	0.0141	CbGbCtD
Quetiapine—ABCB1—Imatinib—hematologic cancer	0.00425	0.0127	CbGbCtD
Quetiapine—CYP3A5—Irinotecan—hematologic cancer	0.00408	0.0122	CbGbCtD
Quetiapine—CYP2D6—Imatinib—hematologic cancer	0.004	0.012	CbGbCtD
Quetiapine—ABCB1—Nilotinib—hematologic cancer	0.00386	0.0115	CbGbCtD
Quetiapine—ABCB1—Vinorelbine—hematologic cancer	0.00383	0.0115	CbGbCtD
Quetiapine—CYP3A4—Methoxsalen—hematologic cancer	0.00365	0.0109	CbGbCtD
Quetiapine—CYP2D6—Nilotinib—hematologic cancer	0.00364	0.0109	CbGbCtD
Quetiapine—CYP2D6—Vinorelbine—hematologic cancer	0.00361	0.0108	CbGbCtD
Quetiapine—CYP3A7—Dexamethasone—hematologic cancer	0.00358	0.0107	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00358	0.0107	CbGbCtD
Quetiapine—CYP3A5—Vincristine—hematologic cancer	0.00356	0.0107	CbGbCtD
Quetiapine—CYP3A4—Bortezomib—hematologic cancer	0.00347	0.0104	CbGbCtD
Quetiapine—CYP2C19—Prednisone—hematologic cancer	0.00347	0.0104	CbGbCtD
Quetiapine—ABCB1—Dasatinib—hematologic cancer	0.00341	0.0102	CbGbCtD
Quetiapine—ABCB1—Mitoxantrone—hematologic cancer	0.00337	0.0101	CbGbCtD
Quetiapine—CYP3A4—Daunorubicin—hematologic cancer	0.00332	0.00994	CbGbCtD
Quetiapine—CYP3A5—Etoposide—hematologic cancer	0.00327	0.00977	CbGbCtD
Quetiapine—ABCB1—Betamethasone—hematologic cancer	0.003	0.00899	CbGbCtD
Quetiapine—ABCB1—Gemcitabine—hematologic cancer	0.00298	0.00891	CbGbCtD
Quetiapine—ABCB1—Prednisolone—hematologic cancer	0.00296	0.00887	CbGbCtD
Quetiapine—CYP3A4—Cytarabine—hematologic cancer	0.00293	0.00877	CbGbCtD
Quetiapine—CYP3A4—Teniposide—hematologic cancer	0.00289	0.00864	CbGbCtD
Quetiapine—ABCB1—Prednisone—hematologic cancer	0.0028	0.00837	CbGbCtD
Quetiapine—CYP3A5—Dexamethasone—hematologic cancer	0.00268	0.00803	CbGbCtD
Quetiapine—CYP3A4—Ifosfamide—hematologic cancer	0.00266	0.00797	CbGbCtD
Quetiapine—ABCB1—Irinotecan—hematologic cancer	0.00265	0.00794	CbGbCtD
Quetiapine—CYP3A4—Imatinib—hematologic cancer	0.00255	0.00762	CbGbCtD
Quetiapine—CYP3A4—Ruxolitinib—hematologic cancer	0.0024	0.00717	CbGbCtD
Quetiapine—ABCB1—Vinblastine—hematologic cancer	0.00236	0.00706	CbGbCtD
Quetiapine—ABCB1—Vincristine—hematologic cancer	0.00232	0.00694	CbGbCtD
Quetiapine—CYP3A4—Nilotinib—hematologic cancer	0.00231	0.00692	CbGbCtD
Quetiapine—CYP3A4—Vinorelbine—hematologic cancer	0.00229	0.00686	CbGbCtD
Quetiapine—CYP2D6—Vinblastine—hematologic cancer	0.00222	0.00665	CbGbCtD
Quetiapine—CYP2C19—Dexamethasone—hematologic cancer	0.00217	0.00648	CbGbCtD
Quetiapine—ABCB1—Cisplatin—hematologic cancer	0.00216	0.00647	CbGbCtD
Quetiapine—ABCB1—Etoposide—hematologic cancer	0.00213	0.00636	CbGbCtD
Quetiapine—CYP3A4—Triamcinolone—hematologic cancer	0.0021	0.00628	CbGbCtD
Quetiapine—CYP3A4—Dasatinib—hematologic cancer	0.00204	0.00612	CbGbCtD
Quetiapine—CYP3A4—Mitoxantrone—hematologic cancer	0.00202	0.00604	CbGbCtD
Quetiapine—CYP3A4—Betamethasone—hematologic cancer	0.0018	0.00538	CbGbCtD
Quetiapine—CYP3A4—Prednisolone—hematologic cancer	0.00178	0.00531	CbGbCtD
Quetiapine—ABCB1—Dexamethasone—hematologic cancer	0.00175	0.00523	CbGbCtD
Quetiapine—CYP3A4—Prednisone—hematologic cancer	0.00168	0.00502	CbGbCtD
Quetiapine—CYP2D6—Dexamethasone—hematologic cancer	0.00165	0.00493	CbGbCtD
Quetiapine—CYP3A4—Irinotecan—hematologic cancer	0.00159	0.00476	CbGbCtD
Quetiapine—ABCB1—Doxorubicin—hematologic cancer	0.00145	0.00434	CbGbCtD
Quetiapine—CYP3A4—Vinblastine—hematologic cancer	0.00141	0.00423	CbGbCtD
Quetiapine—ABCB1—Methotrexate—hematologic cancer	0.0014	0.0042	CbGbCtD
Quetiapine—CYP3A4—Vincristine—hematologic cancer	0.00139	0.00416	CbGbCtD
Quetiapine—CYP2D6—Doxorubicin—hematologic cancer	0.00137	0.00409	CbGbCtD
Quetiapine—CYP3A4—Etoposide—hematologic cancer	0.00127	0.00381	CbGbCtD
Quetiapine—CYP3A4—Dexamethasone—hematologic cancer	0.00105	0.00313	CbGbCtD
Quetiapine—CYP3A4—Doxorubicin—hematologic cancer	0.000868	0.0026	CbGbCtD
Quetiapine—DRD5—hematopoietic system—hematologic cancer	0.000844	0.051	CbGeAlD
Quetiapine—DRD4—testis—hematologic cancer	0.000703	0.0425	CbGeAlD
Quetiapine—H1F0—hematopoietic system—hematologic cancer	0.000653	0.0395	CbGeAlD
Quetiapine—HTR3A—hematopoietic system—hematologic cancer	0.000623	0.0377	CbGeAlD
Quetiapine—CHRM4—testis—hematologic cancer	0.000531	0.0321	CbGeAlD
Quetiapine—H1F0—gonad—hematologic cancer	0.000497	0.03	CbGeAlD
Quetiapine—Olanzapine—H1F0—hematologic cancer	0.000456	0.278	CrCbGaD
Quetiapine—H1F0—blood—hematologic cancer	0.000433	0.0262	CbGeAlD
Quetiapine—HTR1A—hematopoietic system—hematologic cancer	0.000422	0.0255	CbGeAlD
Quetiapine—H1F0—bone marrow—hematologic cancer	0.000419	0.0253	CbGeAlD
Quetiapine—HTR3A—blood—hematologic cancer	0.000413	0.025	CbGeAlD
Quetiapine—HTR7—hematopoietic system—hematologic cancer	0.000403	0.0244	CbGeAlD
Quetiapine—CYP2C19—hematopoietic system—hematologic cancer	0.000394	0.0238	CbGeAlD
Quetiapine—ADRA1A—hematopoietic system—hematologic cancer	0.000389	0.0235	CbGeAlD
Quetiapine—H1F0—lung—hematologic cancer	0.00038	0.0229	CbGeAlD
Quetiapine—HTR3A—lung—hematologic cancer	0.000362	0.0219	CbGeAlD
Quetiapine—H1F0—testis—hematologic cancer	0.000358	0.0216	CbGeAlD
Quetiapine—CYP3A5—hematopoietic system—hematologic cancer	0.00031	0.0187	CbGeAlD
Quetiapine—HTR7—gonad—hematologic cancer	0.000307	0.0185	CbGeAlD
Quetiapine—HRH1—hematopoietic system—hematologic cancer	0.000301	0.0182	CbGeAlD
Quetiapine—ADRA2A—hematopoietic system—hematologic cancer	0.000296	0.0179	CbGeAlD
Quetiapine—CHRM1—lung—hematologic cancer	0.000275	0.0166	CbGeAlD
Quetiapine—HTR7—blood—hematologic cancer	0.000267	0.0161	CbGeAlD
Quetiapine—CYP2C19—blood—hematologic cancer	0.000261	0.0158	CbGeAlD
Quetiapine—H1F0—lymph node—hematologic cancer	0.00026	0.0157	CbGeAlD
Quetiapine—ADRA1A—blood—hematologic cancer	0.000258	0.0156	CbGeAlD
Quetiapine—HTR2A—hematopoietic system—hematologic cancer	0.000251	0.0152	CbGeAlD
Quetiapine—ADRA2C—blood—hematologic cancer	0.000246	0.0148	CbGeAlD
Quetiapine—Clozapine—H1F0—hematologic cancer	0.000238	0.145	CrCbGaD
Quetiapine—HTR7—lung—hematologic cancer	0.000234	0.0142	CbGeAlD
Quetiapine—CYP3A4—hematopoietic system—hematologic cancer	0.000233	0.0141	CbGeAlD
Quetiapine—CHRM3—testis—hematologic cancer	0.000232	0.014	CbGeAlD
Quetiapine—CYP2D6—hematopoietic system—hematologic cancer	0.000229	0.0138	CbGeAlD
Quetiapine—ADRA2A—gonad—hematologic cancer	0.000225	0.0136	CbGeAlD
Quetiapine—DRD2—lung—hematologic cancer	0.000221	0.0134	CbGeAlD
Quetiapine—HTR7—testis—hematologic cancer	0.000221	0.0134	CbGeAlD
Quetiapine—ADRA2C—lung—hematologic cancer	0.000215	0.013	CbGeAlD
Quetiapine—DRD2—testis—hematologic cancer	0.000209	0.0126	CbGeAlD
Quetiapine—CYP3A5—blood—hematologic cancer	0.000206	0.0124	CbGeAlD
Quetiapine—ADRA2C—testis—hematologic cancer	0.000203	0.0123	CbGeAlD
Quetiapine—ADRA2A—blood—hematologic cancer	0.000196	0.0118	CbGeAlD
Quetiapine—HTR2A—gonad—hematologic cancer	0.000191	0.0116	CbGeAlD
Quetiapine—CYP3A5—lung—hematologic cancer	0.00018	0.0109	CbGeAlD
Quetiapine—HRH1—lung—hematologic cancer	0.000175	0.0106	CbGeAlD
Quetiapine—ADRA2A—lung—hematologic cancer	0.000172	0.0104	CbGeAlD
Quetiapine—HTR2A—blood—hematologic cancer	0.000167	0.0101	CbGeAlD
Quetiapine—HRH1—testis—hematologic cancer	0.000165	0.00997	CbGeAlD
Quetiapine—ABCB1—hematopoietic system—hematologic cancer	0.000165	0.00996	CbGeAlD
Quetiapine—ADRA2A—testis—hematologic cancer	0.000162	0.00979	CbGeAlD
Quetiapine—CYP3A4—blood—hematologic cancer	0.000154	0.00932	CbGeAlD
Quetiapine—CYP2D6—blood—hematologic cancer	0.000152	0.00917	CbGeAlD
Quetiapine—Thioproperazine—SLC22A1—hematologic cancer	0.000149	0.0909	CrCbGaD
Quetiapine—ADRA2C—lymph node—hematologic cancer	0.000147	0.0089	CbGeAlD
Quetiapine—Pipotiazine—SLC22A1—hematologic cancer	0.000147	0.0894	CrCbGaD
Quetiapine—Thiothixene—SLC22A1—hematologic cancer	0.000147	0.0894	CrCbGaD
Quetiapine—HTR2A—lung—hematologic cancer	0.000146	0.00883	CbGeAlD
Quetiapine—HTR2A—testis—hematologic cancer	0.000138	0.00833	CbGeAlD
Quetiapine—CYP2D6—testis—hematologic cancer	0.000126	0.00759	CbGeAlD
Quetiapine—ABCB1—gonad—hematologic cancer	0.000125	0.00757	CbGeAlD
Quetiapine—HRH1—lymph node—hematologic cancer	0.00012	0.00723	CbGeAlD
Quetiapine—ADRA2A—lymph node—hematologic cancer	0.000117	0.0071	CbGeAlD
Quetiapine—ABCB1—blood—hematologic cancer	0.000109	0.0066	CbGeAlD
Quetiapine—ABCB1—bone marrow—hematologic cancer	0.000106	0.00638	CbGeAlD
Quetiapine—ABCB1—lung—hematologic cancer	9.57e-05	0.00578	CbGeAlD
Quetiapine—ABCB1—testis—hematologic cancer	9.03e-05	0.00546	CbGeAlD
Quetiapine—Flupentixol—ABCB1—hematologic cancer	8.8e-05	0.0536	CrCbGaD
Quetiapine—ABCB1—lymph node—hematologic cancer	6.55e-05	0.00396	CbGeAlD
Quetiapine—Olanzapine—ALB—hematologic cancer	4.93e-05	0.0301	CrCbGaD
Quetiapine—Nefazodone—ABCB1—hematologic cancer	4.92e-05	0.03	CrCbGaD
Quetiapine—Olanzapine—ABCB1—hematologic cancer	4.71e-05	0.0287	CrCbGaD
Quetiapine—Trazodone—ABCB1—hematologic cancer	4.55e-05	0.0277	CrCbGaD
Quetiapine—Thioproperazine—ALB—hematologic cancer	4.54e-05	0.0277	CrCbGaD
Quetiapine—Pipotiazine—ALB—hematologic cancer	4.47e-05	0.0272	CrCbGaD
Quetiapine—Thiothixene—ALB—hematologic cancer	4.47e-05	0.0272	CrCbGaD
Quetiapine—Fluphenazine—ABCB1—hematologic cancer	3.68e-05	0.0225	CrCbGaD
Quetiapine—Trifluoperazine—ABCB1—hematologic cancer	2.95e-05	0.018	CrCbGaD
Quetiapine—Clozapine—ABCB1—hematologic cancer	2.46e-05	0.015	CrCbGaD
Quetiapine—Dermatitis—Cisplatin—hematologic cancer	1.07e-05	5.19e-05	CcSEcCtD
Quetiapine—Malnutrition—Epirubicin—hematologic cancer	1.07e-05	5.18e-05	CcSEcCtD
Quetiapine—Diarrhoea—Etoposide—hematologic cancer	1.07e-05	5.16e-05	CcSEcCtD
Quetiapine—Anorexia—Prednisone—hematologic cancer	1.06e-05	5.15e-05	CcSEcCtD
Quetiapine—Eye disorder—Doxorubicin—hematologic cancer	1.06e-05	5.15e-05	CcSEcCtD
Quetiapine—Ill-defined disorder—Methotrexate—hematologic cancer	1.06e-05	5.14e-05	CcSEcCtD
Quetiapine—Tinnitus—Doxorubicin—hematologic cancer	1.06e-05	5.14e-05	CcSEcCtD
Quetiapine—Anaemia—Methotrexate—hematologic cancer	1.06e-05	5.12e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Betamethasone—hematologic cancer	1.06e-05	5.12e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Dexamethasone—hematologic cancer	1.06e-05	5.12e-05	CcSEcCtD
Quetiapine—Cardiac disorder—Doxorubicin—hematologic cancer	1.06e-05	5.11e-05	CcSEcCtD
Quetiapine—Flatulence—Epirubicin—hematologic cancer	1.05e-05	5.11e-05	CcSEcCtD
Quetiapine—Tension—Epirubicin—hematologic cancer	1.05e-05	5.09e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.05e-05	5.08e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.05e-05	5.08e-05	CcSEcCtD
Quetiapine—Dysgeusia—Epirubicin—hematologic cancer	1.05e-05	5.08e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Triamcinolone—hematologic cancer	1.04e-05	5.04e-05	CcSEcCtD
Quetiapine—Nervousness—Epirubicin—hematologic cancer	1.04e-05	5.03e-05	CcSEcCtD
Quetiapine—Back pain—Epirubicin—hematologic cancer	1.04e-05	5.01e-05	CcSEcCtD
Quetiapine—Angiopathy—Doxorubicin—hematologic cancer	1.03e-05	5e-05	CcSEcCtD
Quetiapine—Malaise—Methotrexate—hematologic cancer	1.03e-05	4.99e-05	CcSEcCtD
Quetiapine—Dizziness—Etoposide—hematologic cancer	1.03e-05	4.99e-05	CcSEcCtD
Quetiapine—Muscle spasms—Epirubicin—hematologic cancer	1.03e-05	4.98e-05	CcSEcCtD
Quetiapine—Immune system disorder—Doxorubicin—hematologic cancer	1.03e-05	4.98e-05	CcSEcCtD
Quetiapine—Vertigo—Methotrexate—hematologic cancer	1.03e-05	4.98e-05	CcSEcCtD
Quetiapine—Mediastinal disorder—Doxorubicin—hematologic cancer	1.03e-05	4.96e-05	CcSEcCtD
Quetiapine—Leukopenia—Methotrexate—hematologic cancer	1.02e-05	4.96e-05	CcSEcCtD
Quetiapine—Chills—Doxorubicin—hematologic cancer	1.02e-05	4.94e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.02e-05	4.93e-05	CcSEcCtD
Quetiapine—Dizziness—Prednisolone—hematologic cancer	1.02e-05	4.92e-05	CcSEcCtD
Quetiapine—Asthenia—Triamcinolone—hematologic cancer	1.01e-05	4.91e-05	CcSEcCtD
Quetiapine—Body temperature increased—Dexamethasone—hematologic cancer	1.01e-05	4.91e-05	CcSEcCtD
Quetiapine—Abdominal pain—Betamethasone—hematologic cancer	1.01e-05	4.91e-05	CcSEcCtD
Quetiapine—Abdominal pain—Dexamethasone—hematologic cancer	1.01e-05	4.91e-05	CcSEcCtD
Quetiapine—Body temperature increased—Betamethasone—hematologic cancer	1.01e-05	4.91e-05	CcSEcCtD
Quetiapine—Nausea—Cisplatin—hematologic cancer	1.01e-05	4.89e-05	CcSEcCtD
Quetiapine—Insomnia—Prednisone—hematologic cancer	1.01e-05	4.89e-05	CcSEcCtD
Quetiapine—Vision blurred—Epirubicin—hematologic cancer	1.01e-05	4.88e-05	CcSEcCtD
Quetiapine—Paraesthesia—Prednisone—hematologic cancer	1e-05	4.86e-05	CcSEcCtD
Quetiapine—Pruritus—Triamcinolone—hematologic cancer	1e-05	4.84e-05	CcSEcCtD
Quetiapine—Cough—Methotrexate—hematologic cancer	9.98e-06	4.83e-05	CcSEcCtD
Quetiapine—Mental disorder—Doxorubicin—hematologic cancer	9.97e-06	4.83e-05	CcSEcCtD
Quetiapine—Ill-defined disorder—Epirubicin—hematologic cancer	9.93e-06	4.81e-05	CcSEcCtD
Quetiapine—Convulsion—Methotrexate—hematologic cancer	9.91e-06	4.8e-05	CcSEcCtD
Quetiapine—Vomiting—Etoposide—hematologic cancer	9.91e-06	4.8e-05	CcSEcCtD
Quetiapine—Malnutrition—Doxorubicin—hematologic cancer	9.91e-06	4.8e-05	CcSEcCtD
Quetiapine—Anaemia—Epirubicin—hematologic cancer	9.9e-06	4.79e-05	CcSEcCtD
Quetiapine—Agitation—Epirubicin—hematologic cancer	9.84e-06	4.76e-05	CcSEcCtD
Quetiapine—Dyspepsia—Prednisone—hematologic cancer	9.83e-06	4.76e-05	CcSEcCtD
Quetiapine—Rash—Etoposide—hematologic cancer	9.83e-06	4.76e-05	CcSEcCtD
Quetiapine—Dermatitis—Etoposide—hematologic cancer	9.82e-06	4.75e-05	CcSEcCtD
Quetiapine—Headache—Etoposide—hematologic cancer	9.76e-06	4.73e-05	CcSEcCtD
Quetiapine—Flatulence—Doxorubicin—hematologic cancer	9.76e-06	4.73e-05	CcSEcCtD
Quetiapine—Arthralgia—Methotrexate—hematologic cancer	9.74e-06	4.71e-05	CcSEcCtD
Quetiapine—Chest pain—Methotrexate—hematologic cancer	9.74e-06	4.71e-05	CcSEcCtD
Quetiapine—Myalgia—Methotrexate—hematologic cancer	9.74e-06	4.71e-05	CcSEcCtD
Quetiapine—Tension—Doxorubicin—hematologic cancer	9.72e-06	4.71e-05	CcSEcCtD
Quetiapine—Decreased appetite—Prednisone—hematologic cancer	9.71e-06	4.7e-05	CcSEcCtD
Quetiapine—Dysgeusia—Doxorubicin—hematologic cancer	9.7e-06	4.7e-05	CcSEcCtD
Quetiapine—Rash—Prednisolone—hematologic cancer	9.69e-06	4.69e-05	CcSEcCtD
Quetiapine—Dermatitis—Prednisolone—hematologic cancer	9.68e-06	4.69e-05	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	9.67e-06	4.68e-05	CcSEcCtD
Quetiapine—Malaise—Epirubicin—hematologic cancer	9.65e-06	4.67e-05	CcSEcCtD
Quetiapine—Fatigue—Prednisone—hematologic cancer	9.63e-06	4.66e-05	CcSEcCtD
Quetiapine—Headache—Prednisolone—hematologic cancer	9.63e-06	4.66e-05	CcSEcCtD
Quetiapine—Discomfort—Methotrexate—hematologic cancer	9.62e-06	4.66e-05	CcSEcCtD
Quetiapine—Nervousness—Doxorubicin—hematologic cancer	9.62e-06	4.66e-05	CcSEcCtD
Quetiapine—Vertigo—Epirubicin—hematologic cancer	9.62e-06	4.66e-05	CcSEcCtD
Quetiapine—Syncope—Epirubicin—hematologic cancer	9.6e-06	4.65e-05	CcSEcCtD
Quetiapine—Leukopenia—Epirubicin—hematologic cancer	9.58e-06	4.64e-05	CcSEcCtD
Quetiapine—Back pain—Doxorubicin—hematologic cancer	9.58e-06	4.64e-05	CcSEcCtD
Quetiapine—Constipation—Prednisone—hematologic cancer	9.55e-06	4.62e-05	CcSEcCtD
Quetiapine—Muscle spasms—Doxorubicin—hematologic cancer	9.52e-06	4.61e-05	CcSEcCtD
Quetiapine—Palpitations—Epirubicin—hematologic cancer	9.46e-06	4.58e-05	CcSEcCtD
Quetiapine—Confusional state—Methotrexate—hematologic cancer	9.41e-06	4.56e-05	CcSEcCtD
Quetiapine—Loss of consciousness—Epirubicin—hematologic cancer	9.41e-06	4.55e-05	CcSEcCtD
Quetiapine—Dizziness—Triamcinolone—hematologic cancer	9.35e-06	4.53e-05	CcSEcCtD
Quetiapine—Cough—Epirubicin—hematologic cancer	9.34e-06	4.52e-05	CcSEcCtD
Quetiapine—Anaphylactic shock—Methotrexate—hematologic cancer	9.34e-06	4.52e-05	CcSEcCtD
Quetiapine—Vision blurred—Doxorubicin—hematologic cancer	9.34e-06	4.52e-05	CcSEcCtD
Quetiapine—Convulsion—Epirubicin—hematologic cancer	9.28e-06	4.49e-05	CcSEcCtD
Quetiapine—Infection—Methotrexate—hematologic cancer	9.28e-06	4.49e-05	CcSEcCtD
Quetiapine—Nausea—Etoposide—hematologic cancer	9.26e-06	4.48e-05	CcSEcCtD
Quetiapine—Hypertension—Epirubicin—hematologic cancer	9.24e-06	4.47e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Prednisone—hematologic cancer	9.21e-06	4.46e-05	CcSEcCtD
Quetiapine—Asthenia—Betamethasone—hematologic cancer	9.2e-06	4.46e-05	CcSEcCtD
Quetiapine—Asthenia—Dexamethasone—hematologic cancer	9.2e-06	4.46e-05	CcSEcCtD
Quetiapine—Ill-defined disorder—Doxorubicin—hematologic cancer	9.19e-06	4.45e-05	CcSEcCtD
Quetiapine—Nervous system disorder—Methotrexate—hematologic cancer	9.16e-06	4.43e-05	CcSEcCtD
Quetiapine—Anaemia—Doxorubicin—hematologic cancer	9.16e-06	4.43e-05	CcSEcCtD
Quetiapine—Thrombocytopenia—Methotrexate—hematologic cancer	9.14e-06	4.43e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Prednisone—hematologic cancer	9.14e-06	4.42e-05	CcSEcCtD
Quetiapine—Nausea—Prednisolone—hematologic cancer	9.13e-06	4.42e-05	CcSEcCtD
Quetiapine—Arthralgia—Epirubicin—hematologic cancer	9.11e-06	4.41e-05	CcSEcCtD
Quetiapine—Chest pain—Epirubicin—hematologic cancer	9.11e-06	4.41e-05	CcSEcCtD
Quetiapine—Myalgia—Epirubicin—hematologic cancer	9.11e-06	4.41e-05	CcSEcCtD
Quetiapine—Agitation—Doxorubicin—hematologic cancer	9.1e-06	4.41e-05	CcSEcCtD
Quetiapine—Anxiety—Epirubicin—hematologic cancer	9.08e-06	4.4e-05	CcSEcCtD
Quetiapine—Pruritus—Dexamethasone—hematologic cancer	9.08e-06	4.39e-05	CcSEcCtD
Quetiapine—Pruritus—Betamethasone—hematologic cancer	9.08e-06	4.39e-05	CcSEcCtD
Quetiapine—Skin disorder—Methotrexate—hematologic cancer	9.07e-06	4.39e-05	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	9.05e-06	4.38e-05	CcSEcCtD
Quetiapine—Hyperhidrosis—Methotrexate—hematologic cancer	9.03e-06	4.37e-05	CcSEcCtD
Quetiapine—Discomfort—Epirubicin—hematologic cancer	9.01e-06	4.36e-05	CcSEcCtD
Quetiapine—Vomiting—Triamcinolone—hematologic cancer	8.99e-06	4.35e-05	CcSEcCtD
Quetiapine—Malaise—Doxorubicin—hematologic cancer	8.93e-06	4.32e-05	CcSEcCtD
Quetiapine—Rash—Triamcinolone—hematologic cancer	8.91e-06	4.32e-05	CcSEcCtD
Quetiapine—Dry mouth—Epirubicin—hematologic cancer	8.91e-06	4.32e-05	CcSEcCtD
Quetiapine—Dermatitis—Triamcinolone—hematologic cancer	8.91e-06	4.31e-05	CcSEcCtD
Quetiapine—Vertigo—Doxorubicin—hematologic cancer	8.9e-06	4.31e-05	CcSEcCtD
Quetiapine—Anorexia—Methotrexate—hematologic cancer	8.9e-06	4.31e-05	CcSEcCtD
Quetiapine—Syncope—Doxorubicin—hematologic cancer	8.88e-06	4.3e-05	CcSEcCtD
Quetiapine—Leukopenia—Doxorubicin—hematologic cancer	8.87e-06	4.29e-05	CcSEcCtD
Quetiapine—Headache—Triamcinolone—hematologic cancer	8.86e-06	4.29e-05	CcSEcCtD
Quetiapine—Abdominal pain—Prednisone—hematologic cancer	8.83e-06	4.28e-05	CcSEcCtD
Quetiapine—Body temperature increased—Prednisone—hematologic cancer	8.83e-06	4.28e-05	CcSEcCtD
Quetiapine—Confusional state—Epirubicin—hematologic cancer	8.81e-06	4.26e-05	CcSEcCtD
Quetiapine—Diarrhoea—Dexamethasone—hematologic cancer	8.78e-06	4.25e-05	CcSEcCtD
Quetiapine—Diarrhoea—Betamethasone—hematologic cancer	8.78e-06	4.25e-05	CcSEcCtD
Quetiapine—Palpitations—Doxorubicin—hematologic cancer	8.75e-06	4.24e-05	CcSEcCtD
Quetiapine—Anaphylactic shock—Epirubicin—hematologic cancer	8.74e-06	4.23e-05	CcSEcCtD
Quetiapine—Hypotension—Methotrexate—hematologic cancer	8.72e-06	4.22e-05	CcSEcCtD
Quetiapine—Loss of consciousness—Doxorubicin—hematologic cancer	8.71e-06	4.21e-05	CcSEcCtD
Quetiapine—Infection—Epirubicin—hematologic cancer	8.68e-06	4.2e-05	CcSEcCtD
Quetiapine—Cough—Doxorubicin—hematologic cancer	8.64e-06	4.18e-05	CcSEcCtD
Quetiapine—Shock—Epirubicin—hematologic cancer	8.6e-06	4.16e-05	CcSEcCtD
Quetiapine—Convulsion—Doxorubicin—hematologic cancer	8.58e-06	4.15e-05	CcSEcCtD
Quetiapine—Nervous system disorder—Epirubicin—hematologic cancer	8.57e-06	4.15e-05	CcSEcCtD
Quetiapine—Thrombocytopenia—Epirubicin—hematologic cancer	8.55e-06	4.14e-05	CcSEcCtD
Quetiapine—Hypertension—Doxorubicin—hematologic cancer	8.55e-06	4.14e-05	CcSEcCtD
Quetiapine—Tachycardia—Epirubicin—hematologic cancer	8.53e-06	4.13e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	8.51e-06	4.12e-05	CcSEcCtD
Quetiapine—Skin disorder—Epirubicin—hematologic cancer	8.49e-06	4.11e-05	CcSEcCtD
Quetiapine—Dizziness—Betamethasone—hematologic cancer	8.48e-06	4.11e-05	CcSEcCtD
Quetiapine—Dizziness—Dexamethasone—hematologic cancer	8.48e-06	4.11e-05	CcSEcCtD
Quetiapine—Hyperhidrosis—Epirubicin—hematologic cancer	8.45e-06	4.09e-05	CcSEcCtD
Quetiapine—Insomnia—Methotrexate—hematologic cancer	8.44e-06	4.09e-05	CcSEcCtD
Quetiapine—Myalgia—Doxorubicin—hematologic cancer	8.43e-06	4.08e-05	CcSEcCtD
Quetiapine—Arthralgia—Doxorubicin—hematologic cancer	8.43e-06	4.08e-05	CcSEcCtD
Quetiapine—Chest pain—Doxorubicin—hematologic cancer	8.43e-06	4.08e-05	CcSEcCtD
Quetiapine—Anxiety—Doxorubicin—hematologic cancer	8.4e-06	4.07e-05	CcSEcCtD
Quetiapine—Nausea—Triamcinolone—hematologic cancer	8.4e-06	4.07e-05	CcSEcCtD
Quetiapine—Paraesthesia—Methotrexate—hematologic cancer	8.38e-06	4.06e-05	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	8.38e-06	4.05e-05	CcSEcCtD
Quetiapine—Discomfort—Doxorubicin—hematologic cancer	8.33e-06	4.03e-05	CcSEcCtD
Quetiapine—Anorexia—Epirubicin—hematologic cancer	8.33e-06	4.03e-05	CcSEcCtD
Quetiapine—Dyspnoea—Methotrexate—hematologic cancer	8.32e-06	4.03e-05	CcSEcCtD
Quetiapine—Somnolence—Methotrexate—hematologic cancer	8.3e-06	4.02e-05	CcSEcCtD
Quetiapine—Dry mouth—Doxorubicin—hematologic cancer	8.25e-06	3.99e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Prednisone—hematologic cancer	8.23e-06	3.98e-05	CcSEcCtD
Quetiapine—Dyspepsia—Methotrexate—hematologic cancer	8.22e-06	3.98e-05	CcSEcCtD
Quetiapine—Hypotension—Epirubicin—hematologic cancer	8.16e-06	3.95e-05	CcSEcCtD
Quetiapine—Vomiting—Dexamethasone—hematologic cancer	8.16e-06	3.95e-05	CcSEcCtD
Quetiapine—Vomiting—Betamethasone—hematologic cancer	8.16e-06	3.95e-05	CcSEcCtD
Quetiapine—Confusional state—Doxorubicin—hematologic cancer	8.15e-06	3.95e-05	CcSEcCtD
Quetiapine—Decreased appetite—Methotrexate—hematologic cancer	8.12e-06	3.93e-05	CcSEcCtD
Quetiapine—Rash—Dexamethasone—hematologic cancer	8.09e-06	3.92e-05	CcSEcCtD
Quetiapine—Rash—Betamethasone—hematologic cancer	8.09e-06	3.92e-05	CcSEcCtD
Quetiapine—Anaphylactic shock—Doxorubicin—hematologic cancer	8.08e-06	3.91e-05	CcSEcCtD
Quetiapine—Dermatitis—Betamethasone—hematologic cancer	8.08e-06	3.91e-05	CcSEcCtD
Quetiapine—Dermatitis—Dexamethasone—hematologic cancer	8.08e-06	3.91e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Methotrexate—hematologic cancer	8.06e-06	3.9e-05	CcSEcCtD
Quetiapine—Fatigue—Methotrexate—hematologic cancer	8.05e-06	3.9e-05	CcSEcCtD
Quetiapine—Headache—Betamethasone—hematologic cancer	8.04e-06	3.89e-05	CcSEcCtD
Quetiapine—Headache—Dexamethasone—hematologic cancer	8.04e-06	3.89e-05	CcSEcCtD
Quetiapine—Infection—Doxorubicin—hematologic cancer	8.03e-06	3.89e-05	CcSEcCtD
Quetiapine—Asthenia—Prednisone—hematologic cancer	8.02e-06	3.88e-05	CcSEcCtD
Quetiapine—Pain—Methotrexate—hematologic cancer	7.98e-06	3.86e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	7.96e-06	3.85e-05	CcSEcCtD
Quetiapine—Shock—Doxorubicin—hematologic cancer	7.95e-06	3.85e-05	CcSEcCtD
Quetiapine—Nervous system disorder—Doxorubicin—hematologic cancer	7.93e-06	3.84e-05	CcSEcCtD
Quetiapine—Thrombocytopenia—Doxorubicin—hematologic cancer	7.92e-06	3.83e-05	CcSEcCtD
Quetiapine—Pruritus—Prednisone—hematologic cancer	7.9e-06	3.83e-05	CcSEcCtD
Quetiapine—Insomnia—Epirubicin—hematologic cancer	7.9e-06	3.83e-05	CcSEcCtD
Quetiapine—Tachycardia—Doxorubicin—hematologic cancer	7.89e-06	3.82e-05	CcSEcCtD
Quetiapine—Skin disorder—Doxorubicin—hematologic cancer	7.85e-06	3.8e-05	CcSEcCtD
Quetiapine—Paraesthesia—Epirubicin—hematologic cancer	7.85e-06	3.8e-05	CcSEcCtD
Quetiapine—Hyperhidrosis—Doxorubicin—hematologic cancer	7.82e-06	3.78e-05	CcSEcCtD
Quetiapine—Dyspnoea—Epirubicin—hematologic cancer	7.79e-06	3.77e-05	CcSEcCtD
Quetiapine—Somnolence—Epirubicin—hematologic cancer	7.77e-06	3.76e-05	CcSEcCtD
Quetiapine—Anorexia—Doxorubicin—hematologic cancer	7.71e-06	3.73e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Methotrexate—hematologic cancer	7.69e-06	3.72e-05	CcSEcCtD
Quetiapine—Dyspepsia—Epirubicin—hematologic cancer	7.69e-06	3.72e-05	CcSEcCtD
Quetiapine—Diarrhoea—Prednisone—hematologic cancer	7.64e-06	3.7e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Methotrexate—hematologic cancer	7.63e-06	3.7e-05	CcSEcCtD
Quetiapine—Nausea—Betamethasone—hematologic cancer	7.62e-06	3.69e-05	CcSEcCtD
Quetiapine—Nausea—Dexamethasone—hematologic cancer	7.62e-06	3.69e-05	CcSEcCtD
Quetiapine—Decreased appetite—Epirubicin—hematologic cancer	7.6e-06	3.68e-05	CcSEcCtD
Quetiapine—Hypotension—Doxorubicin—hematologic cancer	7.55e-06	3.66e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Epirubicin—hematologic cancer	7.54e-06	3.65e-05	CcSEcCtD
Quetiapine—Fatigue—Epirubicin—hematologic cancer	7.53e-06	3.65e-05	CcSEcCtD
Quetiapine—Pain—Epirubicin—hematologic cancer	7.47e-06	3.62e-05	CcSEcCtD
Quetiapine—Constipation—Epirubicin—hematologic cancer	7.47e-06	3.62e-05	CcSEcCtD
Quetiapine—Dizziness—Prednisone—hematologic cancer	7.39e-06	3.58e-05	CcSEcCtD
Quetiapine—Abdominal pain—Methotrexate—hematologic cancer	7.38e-06	3.57e-05	CcSEcCtD
Quetiapine—Body temperature increased—Methotrexate—hematologic cancer	7.38e-06	3.57e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	7.37e-06	3.57e-05	CcSEcCtD
Quetiapine—Insomnia—Doxorubicin—hematologic cancer	7.31e-06	3.54e-05	CcSEcCtD
Quetiapine—Paraesthesia—Doxorubicin—hematologic cancer	7.26e-06	3.51e-05	CcSEcCtD
Quetiapine—Dyspnoea—Doxorubicin—hematologic cancer	7.21e-06	3.49e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Epirubicin—hematologic cancer	7.2e-06	3.49e-05	CcSEcCtD
Quetiapine—Somnolence—Doxorubicin—hematologic cancer	7.19e-06	3.48e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Epirubicin—hematologic cancer	7.14e-06	3.46e-05	CcSEcCtD
Quetiapine—Dyspepsia—Doxorubicin—hematologic cancer	7.12e-06	3.44e-05	CcSEcCtD
Quetiapine—Vomiting—Prednisone—hematologic cancer	7.1e-06	3.44e-05	CcSEcCtD
Quetiapine—Rash—Prednisone—hematologic cancer	7.04e-06	3.41e-05	CcSEcCtD
Quetiapine—Dermatitis—Prednisone—hematologic cancer	7.04e-06	3.41e-05	CcSEcCtD
Quetiapine—Decreased appetite—Doxorubicin—hematologic cancer	7.03e-06	3.4e-05	CcSEcCtD
Quetiapine—Headache—Prednisone—hematologic cancer	7e-06	3.39e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	6.98e-06	3.38e-05	CcSEcCtD
Quetiapine—Fatigue—Doxorubicin—hematologic cancer	6.97e-06	3.37e-05	CcSEcCtD
Quetiapine—Pain—Doxorubicin—hematologic cancer	6.91e-06	3.35e-05	CcSEcCtD
Quetiapine—Constipation—Doxorubicin—hematologic cancer	6.91e-06	3.35e-05	CcSEcCtD
Quetiapine—Abdominal pain—Epirubicin—hematologic cancer	6.91e-06	3.34e-05	CcSEcCtD
Quetiapine—Body temperature increased—Epirubicin—hematologic cancer	6.91e-06	3.34e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Methotrexate—hematologic cancer	6.88e-06	3.33e-05	CcSEcCtD
Quetiapine—Asthenia—Methotrexate—hematologic cancer	6.7e-06	3.24e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Doxorubicin—hematologic cancer	6.66e-06	3.22e-05	CcSEcCtD
Quetiapine—Nausea—Prednisone—hematologic cancer	6.64e-06	3.21e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.61e-06	3.2e-05	CcSEcCtD
Quetiapine—Pruritus—Methotrexate—hematologic cancer	6.61e-06	3.2e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Epirubicin—hematologic cancer	6.44e-06	3.12e-05	CcSEcCtD
Quetiapine—Abdominal pain—Doxorubicin—hematologic cancer	6.39e-06	3.09e-05	CcSEcCtD
Quetiapine—Body temperature increased—Doxorubicin—hematologic cancer	6.39e-06	3.09e-05	CcSEcCtD
Quetiapine—Diarrhoea—Methotrexate—hematologic cancer	6.39e-06	3.09e-05	CcSEcCtD
Quetiapine—Asthenia—Epirubicin—hematologic cancer	6.27e-06	3.03e-05	CcSEcCtD
Quetiapine—Pruritus—Epirubicin—hematologic cancer	6.18e-06	2.99e-05	CcSEcCtD
Quetiapine—Dizziness—Methotrexate—hematologic cancer	6.17e-06	2.99e-05	CcSEcCtD
Quetiapine—Diarrhoea—Epirubicin—hematologic cancer	5.98e-06	2.89e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Doxorubicin—hematologic cancer	5.96e-06	2.88e-05	CcSEcCtD
Quetiapine—Vomiting—Methotrexate—hematologic cancer	5.94e-06	2.87e-05	CcSEcCtD
Quetiapine—Rash—Methotrexate—hematologic cancer	5.89e-06	2.85e-05	CcSEcCtD
Quetiapine—Dermatitis—Methotrexate—hematologic cancer	5.88e-06	2.85e-05	CcSEcCtD
Quetiapine—Headache—Methotrexate—hematologic cancer	5.85e-06	2.83e-05	CcSEcCtD
Quetiapine—Asthenia—Doxorubicin—hematologic cancer	5.8e-06	2.81e-05	CcSEcCtD
Quetiapine—Dizziness—Epirubicin—hematologic cancer	5.78e-06	2.8e-05	CcSEcCtD
Quetiapine—Pruritus—Doxorubicin—hematologic cancer	5.72e-06	2.77e-05	CcSEcCtD
Quetiapine—Vomiting—Epirubicin—hematologic cancer	5.56e-06	2.69e-05	CcSEcCtD
Quetiapine—Nausea—Methotrexate—hematologic cancer	5.55e-06	2.68e-05	CcSEcCtD
Quetiapine—Diarrhoea—Doxorubicin—hematologic cancer	5.53e-06	2.68e-05	CcSEcCtD
Quetiapine—Rash—Epirubicin—hematologic cancer	5.51e-06	2.67e-05	CcSEcCtD
Quetiapine—Dermatitis—Epirubicin—hematologic cancer	5.5e-06	2.66e-05	CcSEcCtD
Quetiapine—Headache—Epirubicin—hematologic cancer	5.47e-06	2.65e-05	CcSEcCtD
Quetiapine—Dizziness—Doxorubicin—hematologic cancer	5.35e-06	2.59e-05	CcSEcCtD
Quetiapine—Nausea—Epirubicin—hematologic cancer	5.19e-06	2.51e-05	CcSEcCtD
Quetiapine—Vomiting—Doxorubicin—hematologic cancer	5.14e-06	2.49e-05	CcSEcCtD
Quetiapine—Rash—Doxorubicin—hematologic cancer	5.1e-06	2.47e-05	CcSEcCtD
Quetiapine—Dermatitis—Doxorubicin—hematologic cancer	5.09e-06	2.47e-05	CcSEcCtD
Quetiapine—Headache—Doxorubicin—hematologic cancer	5.06e-06	2.45e-05	CcSEcCtD
Quetiapine—Nausea—Doxorubicin—hematologic cancer	4.8e-06	2.32e-05	CcSEcCtD
Quetiapine—HTR6—Signaling Pathways—IL6—hematologic cancer	8.83e-07	9.88e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	8.83e-07	9.87e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—HRAS—hematologic cancer	8.83e-07	9.87e-06	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—hematologic cancer	8.82e-07	9.86e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	8.82e-07	9.86e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	8.8e-07	9.84e-06	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	8.8e-07	9.84e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	8.8e-07	9.84e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ABCB1—hematologic cancer	8.78e-07	9.82e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	8.78e-07	9.81e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	8.77e-07	9.8e-06	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—hematologic cancer	8.77e-07	9.8e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EP300—hematologic cancer	8.77e-07	9.8e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	8.76e-07	9.79e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	8.75e-07	9.78e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	8.74e-07	9.77e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	8.74e-07	9.77e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—hematologic cancer	8.72e-07	9.75e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HRAS—hematologic cancer	8.71e-07	9.73e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	8.7e-07	9.73e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MYC—hematologic cancer	8.7e-07	9.72e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	8.69e-07	9.71e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	8.68e-07	9.7e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	8.66e-07	9.68e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	8.66e-07	9.68e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK3—hematologic cancer	8.66e-07	9.67e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MYC—hematologic cancer	8.65e-07	9.67e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	8.64e-07	9.66e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	8.63e-07	9.65e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EP300—hematologic cancer	8.62e-07	9.64e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EP300—hematologic cancer	8.61e-07	9.62e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—EP300—hematologic cancer	8.6e-07	9.61e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PIK3CA—hematologic cancer	8.59e-07	9.6e-06	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—hematologic cancer	8.58e-07	9.6e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EP300—hematologic cancer	8.58e-07	9.59e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EP300—hematologic cancer	8.55e-07	9.56e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PIK3CA—hematologic cancer	8.55e-07	9.55e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3R1—hematologic cancer	8.53e-07	9.54e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—NCOR1—hematologic cancer	8.53e-07	9.53e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTM1—hematologic cancer	8.53e-07	9.53e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	8.52e-07	9.53e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SRC—hematologic cancer	8.52e-07	9.53e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	8.52e-07	9.52e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	8.51e-07	9.52e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	8.51e-07	9.51e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	8.47e-07	9.47e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	8.47e-07	9.47e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EP300—hematologic cancer	8.47e-07	9.47e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—hematologic cancer	8.45e-07	9.44e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	8.44e-07	9.44e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MYC—hematologic cancer	8.42e-07	9.41e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—hematologic cancer	8.4e-07	9.39e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TGFB1—hematologic cancer	8.4e-07	9.39e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SRC—hematologic cancer	8.39e-07	9.37e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SRC—hematologic cancer	8.37e-07	9.35e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SRC—hematologic cancer	8.34e-07	9.32e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HRAS—hematologic cancer	8.34e-07	9.32e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—hematologic cancer	8.33e-07	9.32e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—hematologic cancer	8.33e-07	9.31e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SRC—hematologic cancer	8.32e-07	9.29e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—hematologic cancer	8.31e-07	9.29e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	8.3e-07	9.28e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	8.28e-07	9.26e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	8.26e-07	9.24e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	8.25e-07	9.22e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SRC—hematologic cancer	8.23e-07	9.2e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	8.23e-07	9.2e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—hematologic cancer	8.22e-07	9.19e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	8.21e-07	9.18e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NRAS—hematologic cancer	8.2e-07	9.17e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—hematologic cancer	8.2e-07	9.16e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—hematologic cancer	8.2e-07	9.16e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	8.17e-07	9.13e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	8.15e-07	9.11e-06	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—hematologic cancer	8.15e-07	9.11e-06	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—hematologic cancer	8.14e-07	9.1e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	8.12e-07	9.08e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	8.1e-07	9.05e-06	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—hematologic cancer	8.09e-07	9.04e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	8.09e-07	9.04e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—hematologic cancer	8.07e-07	9.02e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	8.07e-07	9.02e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	8.07e-07	9.02e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NRAS—hematologic cancer	8.05e-07	9e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	8.05e-07	9e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	8.04e-07	8.99e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	8.04e-07	8.99e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	8.04e-07	8.99e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	8.03e-07	8.97e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	8.03e-07	8.97e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	8.02e-07	8.96e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	8.02e-07	8.96e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	8e-07	8.94e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	8e-07	8.94e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	8e-07	8.94e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—hematologic cancer	7.98e-07	8.92e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HRAS—hematologic cancer	7.95e-07	8.88e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	7.94e-07	8.88e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	7.92e-07	8.86e-06	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—hematologic cancer	7.92e-07	8.85e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	7.92e-07	8.85e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	7.9e-07	8.83e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CB—hematologic cancer	7.87e-07	8.8e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	7.85e-07	8.78e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	7.85e-07	8.77e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	7.84e-07	8.76e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HRAS—hematologic cancer	7.84e-07	8.76e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—hematologic cancer	7.79e-07	8.71e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—hematologic cancer	7.78e-07	8.69e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	7.73e-07	8.64e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	7.71e-07	8.62e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—hematologic cancer	7.69e-07	8.59e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	7.69e-07	8.59e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	7.66e-07	8.56e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	7.66e-07	8.56e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PIK3CA—hematologic cancer	7.65e-07	8.55e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MYC—hematologic cancer	7.64e-07	8.54e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	7.63e-07	8.53e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	7.62e-07	8.52e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—hematologic cancer	7.6e-07	8.5e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	7.59e-07	8.48e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	7.57e-07	8.46e-06	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PIK3CA—hematologic cancer	7.56e-07	8.46e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—MTHFR—hematologic cancer	7.54e-07	8.42e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MYC—hematologic cancer	7.52e-07	8.4e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—hematologic cancer	7.5e-07	8.39e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—hematologic cancer	7.5e-07	8.39e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MYC—hematologic cancer	7.5e-07	8.38e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	7.5e-07	8.38e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	7.48e-07	8.36e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MYC—hematologic cancer	7.48e-07	8.36e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	7.46e-07	8.34e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MYC—hematologic cancer	7.45e-07	8.33e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	7.43e-07	8.31e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	7.43e-07	8.31e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	7.42e-07	8.29e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—hematologic cancer	7.4e-07	8.27e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	7.39e-07	8.25e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MYC—hematologic cancer	7.38e-07	8.25e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—hematologic cancer	7.36e-07	8.23e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	7.36e-07	8.23e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	7.36e-07	8.23e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	7.36e-07	8.23e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	7.35e-07	8.21e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	7.34e-07	8.21e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	7.34e-07	8.21e-06	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—hematologic cancer	7.19e-07	8.04e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PIK3CA—hematologic cancer	7.15e-07	7.99e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—hematologic cancer	7.14e-07	7.99e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—hematologic cancer	7.11e-07	7.94e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HRAS—hematologic cancer	7.08e-07	7.91e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—hematologic cancer	7.06e-07	7.89e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	7.03e-07	7.86e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	7.03e-07	7.86e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—hematologic cancer	7.02e-07	7.84e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—hematologic cancer	6.98e-07	7.8e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—hematologic cancer	6.97e-07	7.79e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	6.94e-07	7.76e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	6.94e-07	7.76e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—hematologic cancer	6.93e-07	7.75e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—hematologic cancer	6.92e-07	7.74e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	6.92e-07	7.74e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—hematologic cancer	6.91e-07	7.73e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	6.91e-07	7.72e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	6.89e-07	7.7e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	6.84e-07	7.64e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	6.83e-07	7.64e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	6.82e-07	7.62e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	6.82e-07	7.62e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—hematologic cancer	6.8e-07	7.61e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	6.8e-07	7.61e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	6.8e-07	7.6e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	6.8e-07	7.6e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—hematologic cancer	6.77e-07	7.57e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—EP300—hematologic cancer	6.65e-07	7.43e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HRAS—hematologic cancer	6.61e-07	7.39e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—hematologic cancer	6.54e-07	7.31e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	6.51e-07	7.27e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—hematologic cancer	6.51e-07	7.27e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—EP300—hematologic cancer	6.49e-07	7.25e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	6.48e-07	7.25e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—hematologic cancer	6.41e-07	7.17e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	6.38e-07	7.13e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	6.37e-07	7.12e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	6.36e-07	7.11e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	6.35e-07	7.09e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	6.33e-07	7.08e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—hematologic cancer	6.33e-07	7.07e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	6.33e-07	7.07e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	6.32e-07	7.06e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—hematologic cancer	6.27e-07	7.01e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	6.26e-07	7e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—hematologic cancer	6.25e-07	6.99e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	6.25e-07	6.98e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	6.23e-07	6.96e-06	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—hematologic cancer	6.18e-07	6.91e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—hematologic cancer	6.17e-07	6.9e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—hematologic cancer	6.16e-07	6.88e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—hematologic cancer	6.14e-07	6.86e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—hematologic cancer	6.12e-07	6.84e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—EP300—hematologic cancer	6.11e-07	6.84e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—hematologic cancer	6.06e-07	6.77e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	6.04e-07	6.76e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	6.03e-07	6.74e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	6e-07	6.71e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HRAS—hematologic cancer	6e-07	6.71e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	5.9e-07	6.6e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HRAS—hematologic cancer	5.89e-07	6.58e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	5.87e-07	6.56e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CREBBP—hematologic cancer	5.87e-07	6.56e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	5.85e-07	6.54e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—hematologic cancer	5.84e-07	6.53e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	5.8e-07	6.49e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	5.8e-07	6.48e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	5.78e-07	6.46e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	5.75e-07	6.42e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—hematologic cancer	5.74e-07	6.42e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—hematologic cancer	5.67e-07	6.34e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—hematologic cancer	5.65e-07	6.31e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—hematologic cancer	5.64e-07	6.3e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—hematologic cancer	5.62e-07	6.28e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	5.62e-07	6.28e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—hematologic cancer	5.6e-07	6.26e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	5.57e-07	6.22e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—hematologic cancer	5.55e-07	6.2e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	5.53e-07	6.18e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—hematologic cancer	5.49e-07	6.14e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	5.37e-07	6e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—hematologic cancer	5.3e-07	5.92e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5.26e-07	5.87e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	5.21e-07	5.83e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—hematologic cancer	5.2e-07	5.81e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—hematologic cancer	5.2e-07	5.81e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	5.18e-07	5.79e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	5.17e-07	5.78e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	5.14e-07	5.75e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	5.12e-07	5.72e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	5.1e-07	5.7e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	4.92e-07	5.5e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	4.85e-07	5.42e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CA—hematologic cancer	4.8e-07	5.37e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	4.74e-07	5.3e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	4.52e-07	5.06e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—hematologic cancer	4.19e-07	4.69e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—hematologic cancer	4.02e-07	4.49e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—EP300—hematologic cancer	4e-07	4.47e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—hematologic cancer	3.92e-07	4.38e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—hematologic cancer	3.7e-07	4.13e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.96e-07	3.31e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—hematologic cancer	2.42e-07	2.7e-06	CbGpPWpGaD
